Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04604132
Title Derazantinib Alone or in Combination With Paclitaxel, Ramucirumab or Atezolizumab in Gastric Adenocarcinoma (FIDES-03)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Basilea Pharmaceutica

gastroesophageal junction adenocarcinoma

gastric adenocarcinoma


Atezolizumab + Derazantinib

Derazantinib + Paclitaxel + Ramucirumab


Paclitaxel + Ramucirumab

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | DEU | BEL

Additional content available in CKB BOOST